Selective serotonin receptor antagonists and therapeutic applications thereof
申请人:——
公开号:US20030232872A1
公开(公告)日:2003-12-18
Spiro[9,10-dihydroanthracene]-9,3′-pyrrolidine (SPAN) and derivatives thereof are provided as selective serotonin receptor antagonists. The compounds are selective, high affinity antagonists of 5-HT
2
serotonin receptors. The compounds are useful as antidepressant and antianxiety agents.